Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
- PMID: 37313280
- PMCID: PMC10258855
- DOI: 10.6004/jadpro.2023.14.4.8
Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
Abstract
Patients with neuroendocrine malignancy with liver metastases are at risk for carcinoid heart disease which, if left unchecked, can lead to heart failure. This case study demonstrates a clinical situation in which an advanced practitioner performed a thorough workup consisting of lab work and imaging studies, including echocardiogram, cardiac MRI, and dotatate PET/CT, as well as outside record review and comprehensive physical exam. Early detection, intervention, and control of disease are paramount to prevent potentially life-limiting carcinoid heart disease.
© 2023 Harborside™.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures


References
-
- Mayo Clinic. (2015). Mayo Clinic announces carcinoid heart disease clinic. https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases...
LinkOut - more resources
Miscellaneous